Mallinckrodt PLC (NYSE:MNK) shares are rocketing a nice 16% after the drug maker unleashed a fourth quarter print that has left Wall Street …
Cantor’s Louise Chen sees two late-stage rare assets gained from MNK’s takeover of Sucampo poised for positive outcomes.
Cantor’s Louise Chen finds MNK’s choice to acquire Sucampo not only an impressive way to close out 2017, but a move that shifts the company’s story beyond leading asset Acthar’s reimbursement challenges.
Canaccord’s Dewey Steadman is positive on the “ideal” Sucampo deal and notes that unlike other pipeline-driven takeovers, short-term profit opportunities will likely content MNK investors.
Canaccord deems crashing MNK shares an overreaction, but cuts price target down over a third.
